Marvel Biosciences Corp. (MRVL.V) TSXV

0.14

-0.015(-9.68%)

Updated at December 24 12:58PM

Currency In CAD

Valuation

Market Cap8.28M
Enterprise Value10.46M
P/E Ratio-3.42
PEG Ratio-0.03
Price/Sales Ratio0
Price/Book Ratio-2.13
Enterprise/Revenue0
Enterprise/EBITDA-4.93

Fiscal Year

Fiscal YearJuly 31, 2025
Most Recent QuarterOctober 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-3.33
Return On Equity0.64

Income Statement

Revenue0
Revenue/Share0
Gross Profit-547,366
EBITDA-1.94M
Net Income-2.21M
Diluted EPS-0.05

Balance Sheet

Total Cash633,536
Total Cash/Share0.01
Total Debt2.31M
Total Debt/Equity-0.63
Current Ratio0.16
Book Value Per Share-0.07

Price History

52-Week Change-9.68
52-Week High0.4
52-Week Low0.08
Moving Average 50 Days0.18
Moving Average 200 Days0.16

Statistics

Average Volume58,742
Shares Outstanding58M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A